Who should not take Sembolic semaglutide
Clin Infect Dis 61:270280 Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
di Villa Bianca Rd, Cirino G, Sorrentino R
Subscribe to our newsletter for the latest insights and trends in the grocery business, or contact us directly at [email protected]
The study, published today in the journal JAMA Network Open, suggests semaglutide is linked to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D)
Acknowledgements The authors would like to thank Thomas Rohban, MD, Julie Nassif, PharmD, and Magalie El Hajj, PharmD, from Partner 4 Health (Paris, France), for providing medical writing support in accordance with Good Publication Practice (GPP3) guidelines